SLC7A11 and neoplasm: Studies have shown that IL-6 can transcriptionally activate the expression of SLC7A11 through the Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT)3 signaling pathway to resist ferroptosis and promote tumor development in HNSCC.